8th Annual Outsourcing in Clinical Trials DACH 2025

Providing a specific platform for the clinical trials community in the DACH region to develop innovative clinical operations and outsourcing strategies.

12 - 13

November

2025
  • Zurich, Switzerland
  • Ticketed
  • Why attend?
  • Agenda
  • OCT Advisory Board
  • Speakers
  • Plan Your Visit
  • Event Gallery
  • Sponsors
  • Media Centre
  • Why partner?
  • Contact Us
close

Why attend?

 

‘Providing a specific platform for the clinical trials community in the DACH region to develop innovative clinical operations and outsourcing strategies’

After a hugely successful 2024 conference, we are pleased to announce that the Outsourcing Clinical Trials DACH event will be returning to zurich. This event will focus upon the operational challenges in clinical development found within Germany, Austria and Switzerland. Over two days, delegates will discuss the common challenges and trends impacting the region, including steps for defining contractual relationships and getting the maximum from external providers, incentivising good relationships with CROs and constructing defined deadlines.

Why Join?

  • Focused conference for the DACH pharma market– Unlike other conferences, our event specifically focuses on the local pharma industry in Switzerland, Germany and Austria, highlighting the current challenges and exciting innovations and opportunities within the market
  • Excellent speaker line up – Senior level speakers from leading organisations such as Roche, AstraZeneca and Novartis along with exciting biotechs like Medac and Medigene
  • Great and Diverse Sessions – Our OCT DACH covers a variety of topics ranging from updated EMA Guidance to Direct to Patient and Data management innovation to CRO relationship
  • Unbeatable Networking Opportunities – Meet and network with over 150 senior industry decision makers during our dedicated networking breaks, round tables and interactive sessions

WHAT TO EXPECT FOR 2025?

Join pharma and biotech experts to discuss new trends and opportunities and learn how they optimize their clinical operations enabling you to stay ahead of the game. Find the right solution providers to partner with, allowing you to accelerate your trial timelines.

200+

Attendees

40+

Speakers

20+

Exhibitors
200+

Attendees

40+

Speakers
20+

Exhibitors

Testimonials

See What It's All About

Agenda

  • 12 Nov 2025
  • 13 Nov 2025
Expand All

Streams

Stream one

STREAM A: Clinical Operations

Stream two

STREAM B: Innovation & Technology

11 AM

Exploring feasibility and AI in pharmaceutical development

  • Enhancing feasibility assessments using AI algorithms
  • Streamlining clinical trial designs with predictive AI models
  • Leveraging AI for identifying optimal patient populations

Reserved for Pfizer representative

11:30 AM

Session reserved for event sponsor

12 PM

FIRESIDE CHAT Exploring recruiting methodologies and digital solutions in clinical trial indications

  • Tailoring recruiting strategies by evaluating what works best across various therapeutic indications
  • Leveraging digital solutions for enhancing candidate engagement in specific clinical trial settings
  • Comparing and refining approaches to align with the unique operational challenges of each indication
  • Integrating data insights for continuously optimizing recruitment practices
  • Innovating methods to ensure the best fit between recruiting tactics and clinical trial environments

Speakers

Thomas Boillat
Digital Health Product Lead, Roche

12:30 PM

Session reserved for event sponsor

12:45 PM

Lunch and networking

2 PM

Transforming patient recruitment with AI

  • Reducing recruitment timelines while improving enrollment success rates
  • Integrating AI with electronic health records (EHR) and real-world data
  • Overcoming ethical and regulatory challenges in AI-powered recruitment

TBD - Piotr Maślak

Speakers

Piotr Maślak
Director, Operational Data Intelligence, AstraZeneca

2:30 PM

Session reserved for event sponsor

3 PM

Navigating digital ethics and AI governance in clinical trials

  • Aligning AI-driven clinical processes with the EU AI Act requirements
  • Balancing patient privacy, data protection, and ethical AI use
  • Ensuring transparency and accountability in AI-powered decision-making

Speakers

Victor Adafinoaiei
Head of Digital Ethics & Compliance by Design, Takeda

3:30 PM

Afternoon refreshments and networking

4 PM

Bridging real-world data and secondary data capture for stronger insights

  • Structuring primary data collection for seamless integration and improved accuracy
  • Aligning regulatory, ethical, and governance frameworks while protecting data integrity
  • Encouraging stakeholder engagement and transparency for trust and usability
  • Optimizing decision-making through comprehensive data utilization

Speakers

Leyla Hernandez Donoso
Senior Director Real World Evidence, Data & Insights, Novo Nordisk

4:30 PM

PANEL DISCUSSION Identifying the right partners to leverage new technologies in pharma

  • Identifying key criteria for selecting the right technology partners in the pharma industry
  • Exploring successful case studies of partnerships leveraging new technologies
  • Understanding the risks and opportunities in collaborating with technology providers to drive innovation in pharma

Speakers

Anja Hipp
Director Technical Development, Oncoteq AG
Victor Adafinoaiei
Head of Digital Ethics & Compliance by Design, Takeda

8 AM

Registration and refreshments

8:50 AM

Chairperson’s opening remarks

9 AM

CASE STUDY Exploring GenAI for transforming clinical trials from theory to therapy

  • Showcasing a real-world use case that explores the future potential of GenAI in clinical trial operations
  • Optimizing trial efficiency and reducing costs through targeted applications of GenAI
  • Inspiring long-term thinking on the strategic business impact of integrating GenAI into clinical development processes

Speakers

Teresa Eastwood-Kiefer
Regulatory Data and Content Chapter and People Leader, Roche

9:30 AM

Session reserved for event sponsor

10 AM

Session reserved for event sponsor

10:30 AM

Morning refreshments and networking

11 AM

CASE STUDY Establishing and expanding registries for global impact

  • Understanding the purpose and value of registries in healthcare
  • Setting up new registries from design to implementation
  • Collaborating with existing registries for data integration and efficiency
  • Developing an umbrella approach for local teams to connect under a global protocol
  • Defining key operational aspects
  • Determining registry duration and appropriate patient enrollment numbers
  • Identifying opportunities for continuous improvement and innovation in registry operations

Speakers

Amir Ahari
Director Clinical Study Management, Novartis

11:30 AM

Session reserved for event sponsor

12 PM

PANEL DISCUSSION Enhancing site engagement and monitoring, strengthening site relationships

  • Building trust while maintaining open communication and understanding site needs
  • Optimizing monitoring practices
  • Using risk-based approaches while ensuring compliance and data integrity
  • Streamlining processes while balancing consistency and local flexibility
  • Improving engagement while addressing challenges from real-world experiences

Speakers

Sarah Bischof
Head of Clinical Development, invIOs
Mireille Ermens
Senior Director, Clinical Development Operations, CSL

12:30 PM

Session reserved for event sponsor

12:45 PM

Lunch and networking

2 PM

Accelerating trial efficiency with adaptive trial design

  • Understanding how adaptive trial design is improving clinical research efficiency
  • Applying real-time data analysis to optimize trial processes and outcomes
  • Navigating regulatory and ethical challenges while accelerating clinical trials

Speakers

Sarah Bischof
Head of Clinical Development, invIOs

2:30 PM

Session reserved for event sponsor

3 PM

CASE STUDY Reimagining clinical trial oversight through risk-based quality management

  • Adopting RBQM strategies to manage global trial complexity and evolving regulations
  • Implementing the Integrated Quality Risk Management Plan to target critical risks
  • Defining and tracking QTL Parameters and KRIs to ensure proactive monitoring
  • Aligning resource use with risk levels to boost trial efficiency and data integrity
  • Learning from Boehringer Ingelheim’s adaptive approach to safeguarding quality and compliance

Speakers

Monika Mörsch
Capability Area Lead RBQM, Boehringer Ingelheim

3:30 PM

Afternoon refreshments and networking

4 PM

Engaging patients early in clinical development for enhanced clinical trial outcomes

  • Developing strategies for involving patients from trial design through implementation
  • Enhancing recruitment, retention, and adherence by suing patient-centric approaches
  • Leveraging digital tools and platforms for real-time patient engagement and data collection
  • Addressing ethical considerations and maintaining trust throughout clinical development

Speakers

Beverly Lui
Patient Advocate

4:30 PM

PANEL DISCUSSION Bridging the early-phase divide: advancing equity by including women in drug development

  • Exploring how and why women continue to be excluded from early-phase (Phase I) clinical trials
  • Examining the historical, regulatory, and ethical reasons driving this underrepresentation
  • Identifying the risks of overlooking sex-based differences in drug metabolism, response, and adverse events
  • Assessing how incomplete data is impacting downstream development, post-market safety, and healthcare outcomes
  • Promoting actionable strategies for building equity into trial design, recruitment, and data reporting

Speakers

Maria Rigoroso-Brandt
Global & US Patient Engagement Lead, Pfizer
Antonella Chadha
Founder and CEO, Women's Brain Foundation
Laura Risueno Ayerbe
Global Patient Affairs, Patient Engagement R&D, Servier

5:15 PM

Chairperson’s closing remarks

DRINKS RECEPTION

8 AM

Registration and refreshments

8:50 AM

Chairperson’s opening remarks

9 AM

PANEL DISCUSSION Exploring shifting clinical trial landscapes and risk strategies

  • Exploring how geopolitics influences clinical trials, from trade policies to international relations
  • Discussing the impact of political changes and potential policy shifts
  • Analyzing regulatory landscapes and incentives in alternative regions
  • Addressing risk factors and strategic decision-making for trial site selection
  • Examining the role of ERCs and strategy departments in navigating global shifts

Speakers

Amir Ahari
Director Clinical Study Management, Novartis
Savitha Ram Moorthi
Director Clinical Compliance & Risk Management, Bristol Myers Squibb

9:45 AM

Balancing in-house expertise and outsourcing for trial success

  • Comparing in-house and outsourced models for clinical trial execution
  • Evaluating decision-making frameworks for choosing the right resourcing strategy
  • Identifying key benefits and trade-offs in quality, speed, and flexibility
  • Exploring hybrid models and integrating CROs or FSPs effectively
  • Adapting operational approaches based on trial complexity, indication, and geography

Speakers

Mireille Ermens
Senior Director, Clinical Development Operations, CSL

10:15 AM

PANEL DISCUSSION Comparing the all-in-one CRO model to specialized CRO models in clinical development

  • Analyzing the efficiency and cost benefits of an all-in-one CRO versus using specialized CROs for different phases
  • Evaluating the flexibility of a multi-CRO model in adapting to diverse project needs and expertise
  • Weighing the risks of relying on a single provider versus the coordination challenges of managing multiple vendors
  • Considering the impact on communication, data integration, and consistency when using a single CRO compared to multiple CROs
  • Discussing the potential for innovation and quality improvements with specialized CROs versus the streamlined approach of an all-in-one model

Speakers

Isabelle Arrighi
Global Director Clinical Operations, Nestle Health Science
Daniel McVeigh
Director, Clinical Operations, Alexion

10:45 AM

Morning refreshments and networking

11:30 AM

Session reserved for GlobalData

12 PM

Strategies to evaluate and reduce site burden and improve operations

  • Assessing site workload to identify operational pain points and streamline trial activities
  • Simplifying protocols and data collection requirements to reduce administrative overhead
  • Supporting sites with tools, training, and resources to enhance efficiency and engagement

Speakers

Isabelle Arrighi
Global Director Clinical Operations, Nestle Health Science

12:30 PM

Overcoming regulatory challenges in multi-country trials

  • Navigating complex regulatory landscapes by understanding country-specific requirements and harmonizing processes
  • Building strong communication channels between regulatory bodies and trial teams to ensure alignment and timely approvals
  • Leveraging technology to streamline compliance documentation and track regulatory milestones across multiple jurisdictions

Speakers

Mara Hummel
Associate Director of Global Clinical Operations, Team Leader, Roche

1 PM

Lunch and networking with Prize Draw at 14:15

2:30 PM

Navigating cultural perspectives while implementing the ICH E6(R3) updates

  • Recognizing how cultural values influence participant engagement and ethical trial design
  • Applying risk-based approaches that address region-specific challenges in clinical research
  • Ensuring adaptability in decentralized trials while maintaining compliance across diverse settingsSavitha Ram Moorthi

Speakers

Savitha Ram Moorthi
Director Clinical Compliance & Risk Management, Bristol Myers Squibb

3 PM

Positioning Switzerland as attractive partner for clinical research outside the EU and CTIS regulation

  • Unlock the Swiss potential - Switzerland's strength and challenges in the clinical trial framework
  • Transforming clinical trials in Switzerland - what can be learnt from others
  • Navigate the future - how Switzerland embarks for a new era fit for the future

Speakers

Ina Meyer
Study & Site Operations Country Manager Switzerland, Novartis on behalf of Interpharma

3:30 PM

PROBLEM-SOLVING ROUNDTABLE DISCUSSIONS

During the roundtable discussion session, the conference hall will be divided into three ‘zones’. Delegates can choose which zone they would like to join. Each zone will be led by a table moderator and will focus on a different challenge within clinical operations in oncology trials. After 30 minutes, delegates will have the opportunity to swap and choose a different table, and each roundtable will run twice.

ROUNDTABLE 1
Strengthening partnerships with CROs for enhanced registry success
Amir Ahari, Director Clinical Study Management, Novartis

ROUNDTABLE 2
Enhancing collaboration between clinical operations and clinical supply
Marie Rasoanandrasana, Head, Supply Chain and Vendor Management, Debiopharm Group

ROUNDTBALE 3
Is it worth it? Evaluating ROI in pharma’s investment in technology

Speakers

Amir Ahari
Director Clinical Study Management, Novartis
Marie Rasoanandrasana
Head, Supply Chain and Vendor Management, Debiopharm Group

4:30 PM

Chairperson’s closing remarks

END OF CONFERENCE

Speakers

Select a speaker to learn more

Back
Sarah Bischof
Head of Clinical Development, invIOs

Session Details:

Accelerating trial efficiency with adaptive trial design

2025-11-12, 2:00 PM

Session Details:

PANEL DISCUSSION Enhancing site engagement and monitoring, strengthening site relationships

2025-11-12, 12:00 PM

View In Agenda
Next speaker
Back
Ina Meyer
Study & Site Operations Country Manager Switzerland, Novartis on behalf of Interpharma

Session Details:

Positioning Switzerland as attractive partner for clinical research outside the EU and CTIS regulation

2025-11-13, 3:00 PM

View In Agenda
Next speaker
Back
Daniel McVeigh
Director, Clinical Operations, Alexion

Session Details:

PANEL DISCUSSION Comparing the all-in-one CRO model to specialized CRO models in clinical development

2025-11-13, 10:15 AM

View In Agenda
Next speaker
Back
Amir Ahari
Director Clinical Study Management, Novartis

Session Details:

CASE STUDY Establishing and expanding registries for global impact

2025-11-12, 11:00 AM

Session Details:

PROBLEM-SOLVING ROUNDTABLE DISCUSSIONS

2025-11-13, 3:30 PM

Session Details:

PANEL DISCUSSION Exploring shifting clinical trial landscapes and risk strategies

2025-11-13, 9:00 AM

View In Agenda
Next speaker
Back
Thomas Boillat
Digital Health Product Lead, Roche

Session Details:

FIRESIDE CHAT Exploring recruiting methodologies and digital solutions in clinical trial indications

2025-11-12, 12:00 PM

View In Agenda
Next speaker
Back
Monika Mörsch
Capability Area Lead RBQM, Boehringer Ingelheim

Session Details:

CASE STUDY Reimagining clinical trial oversight through risk-based quality management

2025-11-12, 3:00 PM

View In Agenda
Next speaker
Back
Leyla Hernandez Donoso
Senior Director Real World Evidence, Data & Insights, Novo Nordisk

Session Details:

Bridging real-world data and secondary data capture for stronger insights

2025-11-12, 4:00 PM

View In Agenda
Next speaker
Back
Savitha Ram Moorthi
Director Clinical Compliance & Risk Management, Bristol Myers Squibb

Session Details:

PANEL DISCUSSION Exploring shifting clinical trial landscapes and risk strategies

2025-11-13, 9:00 AM

Session Details:

Navigating cultural perspectives while implementing the ICH E6(R3) updates

2025-11-13, 2:30 PM

View In Agenda
Next speaker
Back
Anja Hipp
Director Technical Development, Oncoteq AG

Session Details:

PANEL DISCUSSION Identifying the right partners to leverage new technologies in pharma

2025-11-12, 4:30 PM

View In Agenda
Next speaker
Back
Beverly Lui
Patient Advocate

Session Details:

Engaging patients early in clinical development for enhanced clinical trial outcomes

2025-11-12, 4:00 PM

View In Agenda
Next speaker
Back
Isabelle Arrighi
Global Director Clinical Operations, Nestle Health Science

Session Details:

PANEL DISCUSSION Comparing the all-in-one CRO model to specialized CRO models in clinical development

2025-11-13, 10:15 AM

Session Details:

Strategies to evaluate and reduce site burden and improve operations

2025-11-13, 12:00 PM

View In Agenda
Next speaker
Back
Victor Adafinoaiei
Head of Digital Ethics & Compliance by Design, Takeda

Session Details:

Navigating digital ethics and AI governance in clinical trials

2025-11-12, 3:00 PM

Session Details:

PANEL DISCUSSION Identifying the right partners to leverage new technologies in pharma

2025-11-12, 4:30 PM

View In Agenda
Next speaker
Back
Maria Rigoroso-Brandt
Global & US Patient Engagement Lead, Pfizer

Session Details:

PANEL DISCUSSION Bridging the early-phase divide: advancing equity by including women in drug development

2025-11-12, 4:30 PM

View In Agenda
Next speaker
Back
Mireille Ermens
Senior Director, Clinical Development Operations, CSL

Mireille Ermens, is a seasoned leader in the field of clinical research and healthcare management with a rich background spanning over two decades. Armed with a degree of Socio Medical Science with distinction from the University Ghent, Belgium, Mireille brings a unique blend of expertise in biochemistry, mathematics, statistics, and preventive healthcare.

A true polyglot, Mireille is fluent in Dutch, French, and English, with proficiency in German and Spanish, reflecting a deep commitment to effective communication across diverse cultural landscapes.

With a leadership style centered around "Building Bridges with and for People," Mireille has led clinical development operations teams, navigating challenges in rare and chronic diseases, high-volume infectious diseases and seasonal vaccine environments.

Currently serving as the Senior Director of Global Feasibility and Start Up Support at CSL Limited, Mireille spearheads strategic assessments of clinical trial feasibility, facilitating optimal business decision-making through meticulous recruitment-time-cost analyses and evaluation of execution options.

Prior to this role, Mireille served as the Head of Global Site Management and Monitoring Oversight at CSL Seqirus, while advocating for global process consistency with a patient-oriented oversight agility. Mireille's extensive experience also includes senior positions at Eli Lilly and Hoffmann-La Roche.

Mireille began her career as an ICU Coordinator in Intensive Care at the University Hospital, Ghent, monitoring and caring for patients post-cardiac surgery, demonstrating a commitment to hands-on patient care.

With a career trajectory marked by innovation, strategic vision, and a relentless pursuit of excellence, Mireille is a dynamic speaker who brings a wealth of knowledge and expertise to any discussion on clinical research, healthcare management, and leadership in the pharmaceutical industry.

Session Details:

PANEL DISCUSSION Enhancing site engagement and monitoring, strengthening site relationships

2025-11-12, 12:00 PM

Session Details:

Balancing in-house expertise and outsourcing for trial success

2025-11-13, 9:45 AM

View In Agenda
Next speaker
Back
Antonella Chadha
Founder and CEO, Women's Brain Foundation

Session Details:

PANEL DISCUSSION Bridging the early-phase divide: advancing equity by including women in drug development

2025-11-12, 4:30 PM

View In Agenda
Next speaker
Back
Mara Hummel
Associate Director of Global Clinical Operations, Team Leader, Roche

Session Details:

Overcoming regulatory challenges in multi-country trials

2025-11-13, 12:30 PM

View In Agenda
Next speaker
Back
Laura Risueno Ayerbe
Global Patient Affairs, Patient Engagement R&D, Servier

Session Details:

PANEL DISCUSSION Bridging the early-phase divide: advancing equity by including women in drug development

2025-11-12, 4:30 PM

View In Agenda
Next speaker
Back
Teresa Eastwood-Kiefer
Regulatory Data and Content Chapter and People Leader, Roche

Session Details:

CASE STUDY Exploring GenAI for transforming clinical trials from theory to therapy

2025-11-12, 9:00 AM

View In Agenda
Next speaker
Back
Marie Rasoanandrasana
Head, Supply Chain and Vendor Management, Debiopharm Group

Session Details:

PROBLEM-SOLVING ROUNDTABLE DISCUSSIONS

2025-11-13, 3:30 PM

View In Agenda
Next speaker

OCT Advisory Board

Select a member to learn more

Back
Rosalie Filling
Vice President, Senior Global Head R&D Operations, Endo Pharmaceuticals

In her over 25 years of experience, Rosalie “Rosie” Filling has transformed R&D operations in every company she has worked for, developing clear-cut strategies to help advance clinical trials with high-quality operational execution and scientific excellence.

 

Rosie is the Vice President, Senior Global Head R&D Operations Endo International plc. She is part of the global R&D leadership team and is charged with the coordination and implementation of clinical development strategies for the company’s research and development. She provides strategic direction and oversight of the R&D Operations team, which includes clinical operations, data management, biostatistics, medical writing, clinical supplies, trial master file/inspection readiness and business operations. This integrated team handles the execution of all aspects related to Endo’s clinical trials. Endo has active research and development programs in men’s health, orthopedics, and endocrinology. Beyond these therapeutic areas, the company also has focused development in the areas of sterile injectables and complex generic products.

 

Rosie’s main focus at all times is on the end users—the patients. Bringing new and, at times, life-saving medications to patients drives Rosie’s sense of purpose.

 

Rosie joined Endo from Lupin Pharmaceuticals in Blue Bell, PA where she was Senior Director, Head of Clinical Operations, and built the clinical operations organization to support the US and Global R&D Organization. Prior to Lupin, Rosie spent nearly five years at Teva in Frazer, PA where she was the US site head of Clinical Operations and was responsible for the successful delivery of Inhalation, Women’s Health, and Cardiovascular clinical trials. Earlier in her career, Rosie held various roles at Eisai, MGI Pharma and PPD.

 

Rosie earned her B.S. in Biology with a minor in Chemistry from the University of Pittsburgh.

Next
Back
Kathleen Cohen
Vice President, Clinical Development, Marinus Pharmaceuticals

Kathleen Frenia Cohen is Vice President and Head of Clinical Development Operations at Marinus Pharmaceuticals.  Prior to joining Marinus, she spent 20+ years at PRA Health Sciences in a variety of project management and operational oversite roles. Kathleen graduated from the University of the Science in Philadelphia with a PharmD and completed a post-doctoral fellowship in Pharmacoeconomics and Outcomes Research from Rutgers College of Pharmacy. Kathleen resides in Media, PA.

Next
Back
THOMAS M TREMBLAY
Vice President Of Clinical Development, Trefoil Therapeutics, Inc

Thomas is a registered nurse with both clinical and over 30 years pharmaceutical development experience. His pharmaceutical development experience includes clinical operations, clinical science, clinical development, drug safety and quality. He is currently Vice President of Clinical Development at Trefoil Therapeutics and adjunct faculty at San Francisco State University.

Next
Back
Behtash Bahador
Director, Health Literacy, CISCRP

Behtash Bahador is the Director of Health Literacy at the non-profit organization CISCRP, and holds a Master of Science in Health Communication from the Tufts University School of Medicine. Since 2014, he has collaborated with a range of stakeholder groups to establish and implement patient- and public-centric initiatives across the life-cycle of drug and treatment development. This has included supporting the development of regulatory and cross-disciplinary best practice guidelines, operationalizing key elements of evidence-based public health programing into research engagement activities, and always keeping the needs of patients, participants and the public at the forefront of his work.

Next
Back
Bao Dinh
Global Development Business Operation, Takeda

With over 15 years of experience in Clinical Data Management, Bao leads business strategy and vendor operations for Takeda’s Clinical Data Management, Clinical Data Engineering, and Clinical Data Standards groups, driving organizational growth, managing global FSP partnerships, and enhancing cross-functional collaboration. As a member of the 2024–2025 OCT Advisory Board, Bao brings expertise in clinical outsourcing, strategic vendor partnerships, and RFP process optimization, providing a fresh vision for the organization.

Beyond professional achievements, Bao is dedicated to fostering collaboration and investing in the local community. As a partner of The Town FC and a Silicon Valley angel investor, Bao champions ventures that advance sustainable growth, youth enrichment, and innovation in technology.’

Next

Plan Your Visit

Kameha Grand Zurich, Autograph Collection

The Circle 41 Kloten 8058 Switzerland

Book Your Stay

Accommodation

Arena International Events Group “(Arena”) is aware of numerous third-party agencies which are contacting Arena’s customers and purporting to have access to hotel room bookings, events attendee lists and selling unsolicited services. It is unclear whether the agencies in question are in possession of such information, or whether they intend to scam unsuspecting customers. Whilst Arena International Events Group pursues such third-party companies for their potentially illicit activity, Arena encourages you to be cautious in engaging with such third-party agencies and Arena shall not accept any responsibility for any losses incurred by you should you choose to engage with third parties that have no affiliation to Arena International Events Group..

Sponsors

Select a sponsor to learn more

FEATURED SPONSORS

SESSION SPONSORS

Technology Showcase Sponsor

DRINKS RECEPTION SPONSOR

BADGE SPONSOR

EXHIBITORS

Why partner?

 

Contact us to become a partner

Partnership Opportunities

We work with you to design a bespoke package to meet your business needs, where you could:

  • Demonstrate your expertise on the agenda – have the attention of the entire audience. For greatest impact, why not position your talk before a networking break and immediately conduct follow up conversations with highly engaged attendees
  • Showcase your business and its services at an exhibition booth, which provides a perfect meeting place for prospective new clients
    Present the value proposition of your offering over your competitors, in front of an audience of active, engaged potential customers
  • Speak with key decision makers as part of our intimate, interactive roundtable style workshop sessions with over 8 hours allowed for networking

Event reach

  • 200+ attendees each year
  • 80% attendees C-suite level

 

Take a look at our current sponsors

Media Centre

Become A Media Partner

WHAT TO EXPECT FOR 2025

Join pharma and biotech experts to discuss new trends and opportunities and learn how they optimize their clinical operations enabling you to stay ahead of the game.

 

Find the right solution providers to partner with, allowing you to accelerate your trial timelines.

See What It's All About

Enquiry

Contact Us

SPONSORSHIP ENQUIRIES

Alex Purnell

Senior Sponsorship Manager

+44 20 4540 7786

SPEAKER & MARKETING ENQUIRIES

Ralitsa Pashkuleva

Conference Producer

+44 20 7661 7976

DELEGATE ENQUIRIES

Sunny Saikia

VIP Delegate Manager

SPONSORSHIP ENQUIRIES

To enquire about sponsorship opportunities for the conference, please contact:

Alex Purnell

Senior Sponsorship Manager


+44 204540 7786

SPEAKER ENQUIRIES

To enquire about speaking opportunities for the conference, please contact:

Ralitsa Pashkuleva

Conference Producer


+44 207661 7976